Pharmacogenomic testing, also known as pharmacogenetics or PGx testing, is a specialized type of genetic testing that examines how an individual’s genetic makeup influences their response to medications. It involves analyzing specific genes that play a role in drug metabolism, transport, and the body’s biological pathways related to drug effects. The goal of pharmacogenomic testing is to tailor medical treatment to an individual’s unique genetic profile, leading to safer and more effective medication regimens.
View the CDC’s Table of Pharmacogenomic Biomarkers in Drug Labeling
Improve Patient Care and Outcomes
Reduce Overall Costs Through Precision Medicine Applications
Make Better and More Timely Clinical Decisions
This highly complex PGx data is distilled down into easy-to-review and interpretable reports with actionable recommendations for healthcare professionals. These detailed reports incorporate all CPIC guidelines. Here are examples of a Short Report and a Long Report:
Incite Health provides:
State-of-the-art pharmacogenomic technology and advanced data analysis capabilities.
Comprehensive and customizable pharmacogenomic testing panels.
Strong collaborations with leading genetic researchers and healthcare institutions.
